Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline
<p>Abstract</p> <p>Background</p> <p>Carcinoma of the esophagus is an aggressive malignancy with an increasing incidence. Its virulence, in terms of symptoms and mortality, justifies a continued search for optimal therapy. A clinical practice guideline was developed bas...
Main Authors: | Rumble R Bryan, Wong Rebecca KS, Malthaner Richard A, Zuraw Lisa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-09-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/4/67 |
Similar Items
-
Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis
by: Rumble R Bryan, et al.
Published: (2004-09-01) -
The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: a practice guideline
by: Rumble R Bryan, et al.
Published: (2003-11-01) -
Follow-up of patients with curatively resected colorectal cancer: a practice guideline
by: McLeod Robin, et al.
Published: (2003-10-01) -
Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?
by: Xu Yaping, et al.
Published: (2012-08-01) -
Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series
by: Christina Hadzitheodorou, et al.
Published: (2017-04-01)